Nothing Special   »   [go: up one dir, main page]

PL2073008T3 - Ulepszone sposoby prowadzenia testów immunologicznych - Google Patents

Ulepszone sposoby prowadzenia testów immunologicznych

Info

Publication number
PL2073008T3
PL2073008T3 PL09004778T PL09004778T PL2073008T3 PL 2073008 T3 PL2073008 T3 PL 2073008T3 PL 09004778 T PL09004778 T PL 09004778T PL 09004778 T PL09004778 T PL 09004778T PL 2073008 T3 PL2073008 T3 PL 2073008T3
Authority
PL
Poland
Prior art keywords
immunoassay methods
improved immunoassay
antibody
improved
relats
Prior art date
Application number
PL09004778T
Other languages
English (en)
Inventor
John Forsyth Russell Robertson
Tony Barnes
Andrea Murray
Caroline Chapman
Original Assignee
Oncimmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncimmune Ltd filed Critical Oncimmune Ltd
Publication of PL2073008T3 publication Critical patent/PL2073008T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL09004778T 2005-05-27 2006-05-26 Ulepszone sposoby prowadzenia testów immunologicznych PL2073008T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US68542205P 2005-05-27 2005-05-27
GB0510943A GB2426581A (en) 2005-05-27 2005-05-27 Immunoassay methods
EP06744011A EP1889059B1 (en) 2005-05-27 2006-05-26 Improved immunoassay methods
EP09004778A EP2073008B1 (en) 2005-05-27 2006-05-26 Improved immunoassay methods

Publications (1)

Publication Number Publication Date
PL2073008T3 true PL2073008T3 (pl) 2012-09-28

Family

ID=34834805

Family Applications (2)

Application Number Title Priority Date Filing Date
PL09004778T PL2073008T3 (pl) 2005-05-27 2006-05-26 Ulepszone sposoby prowadzenia testów immunologicznych
PL06744011T PL1889059T3 (pl) 2005-05-27 2006-05-26 Uproszczone sposoby prowadzenia testów immunologicznych

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL06744011T PL1889059T3 (pl) 2005-05-27 2006-05-26 Uproszczone sposoby prowadzenia testów immunologicznych

Country Status (19)

Country Link
US (1) US8722339B2 (pl)
EP (3) EP2275815B1 (pl)
JP (1) JP4876127B2 (pl)
KR (1) KR101400986B1 (pl)
CN (2) CN102749447B (pl)
AT (2) ATE436018T1 (pl)
AU (1) AU2006250923B2 (pl)
CA (1) CA2609793C (pl)
DE (1) DE602006007703D1 (pl)
DK (3) DK2275815T3 (pl)
ES (3) ES2458105T3 (pl)
GB (1) GB2426581A (pl)
MX (1) MX2007014815A (pl)
NO (1) NO339224B1 (pl)
PL (2) PL2073008T3 (pl)
PT (2) PT2275815E (pl)
RU (1) RU2416095C2 (pl)
SI (1) SI2073008T1 (pl)
WO (1) WO2006126008A2 (pl)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136311A (en) 1996-05-06 2000-10-24 Cornell Research Foundation, Inc. Treatment and diagnosis of cancer
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) * 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US20030232399A1 (en) * 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
GB2395270B (en) 2002-11-14 2006-08-16 Univ Nottingham Tumour marker proteins and uses thereof
US7858323B2 (en) 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
SI1889059T1 (sl) 2005-05-27 2009-12-31 Oncimmune Ltd Izboljšani imunotestni postopek
US9347945B2 (en) * 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
CA2634797A1 (en) * 2005-12-22 2007-07-05 Abbott Laboratories Methods and marker combinations for screening for predisposition to lung cancer
CA2646329C (en) 2006-03-20 2018-07-03 The Regents Of The University Of California Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
CA2663154C (en) * 2006-09-13 2016-02-23 Oncimmune Ltd Improved immunoassay methods
CN101632020B (zh) 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
WO2008042508A1 (en) * 2006-10-03 2008-04-10 University Of Southern California Grp78 as a predictor of responsiveness to therapeutic agents
ES2530209T3 (es) * 2007-02-23 2015-02-27 Physicians Choice Laboratory Services, Llc Métodos diagnósticos dirigidos a intervención clínica
US8940298B2 (en) 2007-09-04 2015-01-27 The Regents Of The University Of California High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection
CN101925364B (zh) 2007-11-27 2014-04-30 不列颠哥伦比亚大学 用于预防和治疗关节炎的14-3-3拮抗剂
GB0725239D0 (en) * 2007-12-24 2008-02-06 Oncimmune Ltd Calibrator for autoantibody assay
EP2623985A1 (en) * 2008-02-21 2013-08-07 Iris International, Inc. Method for early determination of recurrence after therapy for prostate cancer
CN102216772B (zh) * 2008-09-19 2014-11-26 里奇维尤诊断公司 用于固体生物对象的分析的方法
EP2389585A2 (en) * 2009-01-22 2011-11-30 Li-Cor, Inc. Single molecule proteomics with dynamic probes
EP3495000A1 (en) 2009-02-17 2019-06-12 Cornell Research Foundation, Inc. Methods and kits for diagnosis of cancer and prediction of therapeutic value
BRPI1009573A2 (pt) * 2009-03-11 2017-07-18 Augurex Life Sciences Corp método para avaliar uma condição artrítica em um sujeito, kit para detectar a presença de um auto-anticorpo, e, método para determinar o subtipo de artrite em um paciente.
SG176962A1 (en) * 2009-06-23 2012-01-30 Eventus Diagnostics Israel Ltd A method and system for the detection of cancer
CN101762700A (zh) * 2009-06-24 2010-06-30 北京科美东雅生物技术有限公司 一种定量检测血液中癌胚抗原的磁性免疫层析试纸条及制备方法
ES2711504T3 (es) 2009-07-24 2019-05-06 Rhode Island Hospital Vacunas de células dendríticas para tumores que expresan asparaginil-beta-hidroxilasa
ES2796530T3 (es) * 2009-10-26 2020-11-27 Prometheus Biosciences Inc Ensayos para la detección de fármacos anti-TNF y autoanticuerpos
CA3040276A1 (en) 2009-12-02 2011-06-09 Imaginab, Inc. J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
EP3450979A3 (en) 2010-03-17 2019-04-24 The Regents of The University of Michigan Using phage epitopes to profile the immune response
EP2569639B1 (en) 2010-05-12 2015-02-11 Hill's Pet Nutrition, Inc. Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines
US20130310266A1 (en) * 2010-09-03 2013-11-21 Immport Therapeutics, Inc. Methods and Compositions For The Diagnosis And Treatment Of Cancer and Autoimmune Disorders
WO2012045279A1 (en) * 2010-10-08 2012-04-12 Shanghai Kexin Biotech Co., Ltd. Moesin fragments associated with immune thrombocytopenia
EA018848B1 (ru) * 2010-10-20 2013-11-29 Вадим Юльевич ШАНИН Иммунологически активное вещество, способ его получения, биозонд на его основе и способ диагностики состояния здоровья с применением биозонда, фармацевтическая композиция и способ лечения с использованием фармацевтической композиции
CN102125698A (zh) * 2010-11-29 2011-07-20 昆明理工大学 具有正常免疫功能的小鼠移植肿瘤模型的建立方法
CA2840590C (en) 2011-07-01 2018-09-04 Inova Diagnostics, Inc. Method for increasing specificity of diagnostic tests for autoimmune diseases
HUE035999T2 (hu) 2011-10-21 2018-06-28 Augurex Life Sciences Corp Citrullinezett 14-3-3 peptidekbõl származó antigének és azok alkalmazásai a reumatoid artritisz diagnózisában
CN102590530B (zh) * 2012-03-02 2014-06-25 常晓天 Krt84自我免疫抗体作为诊断、检测类风湿性关节炎的诊断标记物的应用
CN104428674A (zh) * 2012-04-24 2015-03-18 思研(Sri)国际顾问与咨询公司 前列腺癌和sar-cov的人血清生物标记物
US20150362497A1 (en) * 2013-01-31 2015-12-17 Arizona Board of Regents on behalf of Arizona Stat State University Autoantibody Signature for the Early Detection of Ovarian Cancer
CN103604923B (zh) * 2013-10-22 2015-05-13 卫生部北京医院 检测抗甲状腺过氧化物酶和甲状腺球蛋白的天然双特异性抗体的试剂盒
RU2678135C1 (ru) * 2014-02-05 2019-01-23 Фуджиребио Диагностикс Аб Композиция и способ для детектирования злокачественного неопластического заболевания
GB201411060D0 (en) * 2014-06-20 2014-08-06 Oncimmune Ltd Improved immunoassay method
CN104356226B (zh) * 2014-11-04 2017-03-29 青岛海兰深生物科技有限公司 一种检测血浆免疫标志物‑vegfr1自身抗体的抗原多肽及应用
MX2018001566A (es) 2015-08-07 2019-04-25 Imaginab Inc Construcciones de union a antigeno para moleculas diana.
JP6818753B2 (ja) * 2015-12-11 2021-01-20 サンフォード ヘルス 乳癌治療を監視するための試薬及び方法
CN106053812B (zh) * 2016-06-29 2017-12-08 厦门生迪生物技术有限公司 一种用于肝癌早期筛查和诊断的多种自身抗体联合检测elisa试剂盒
JP6334017B1 (ja) * 2017-01-25 2018-05-30 ファナック株式会社 誘導電動機の制御装置
WO2018147960A1 (en) 2017-02-08 2018-08-16 Imaginab, Inc. Extension sequences for diabodies
CN111108388A (zh) * 2017-06-23 2020-05-05 昂西免疫德国有限公司 用于治疗癌症的免疫肿瘤学
WO2019152498A1 (en) * 2018-02-01 2019-08-08 Sedia Biosciences Corporation A rapid quantitative assay to assess duration of infection
KR20230068378A (ko) 2020-07-14 2023-05-17 오엔씨이뮨리미티드 폐암에서 자가항체를 검출하기 위한 항원 조합의 용도
GB2600701A (en) 2020-11-04 2022-05-11 Oncimmune Ltd Antibody assay
CN112345755B (zh) * 2020-09-23 2023-06-16 杭州凯保罗生物科技有限公司 乳腺癌的生物标志物及其应用
GB2622246A (en) 2022-09-08 2024-03-13 Oncimmune Germany Gmbh Antibody assay

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ211453A (en) 1984-03-22 1989-01-06 Biotechnology Research Enterpr Aryl azides, their preparation and use in the detection, localisation and isolation of polynucleotides
EP0236606B1 (en) 1986-03-10 1992-06-24 Imre Corporation Immune complex assay
US4925788A (en) * 1986-10-24 1990-05-15 Immunicon Corporation Immunoassay system and procedure based on precipitin-like interaction between immune complex and Clq or other non-immunospecific factor
WO1989001153A1 (en) 1987-07-24 1989-02-09 Xoma Corporation Methods for breast cancer detection
US4937185A (en) 1987-07-31 1990-06-26 The Ohio State University Research Foundation Detection of circulating antibodies to a cancer marker protein
US7282345B1 (en) 1989-08-04 2007-10-16 Schering Ag C-erbB-2 external domain: GP75
US5157020A (en) 1990-05-24 1992-10-20 Research Corporation Tech., Inc. Synthetic senescent cell antigen
DK9091D0 (da) 1991-01-18 1991-01-18 Novo Nordisk As Fremgangsmaade til fremstilling af antistoffer
DE4120412C1 (pl) * 1991-06-20 1993-01-07 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin, De
US6280962B1 (en) 1991-11-25 2001-08-28 Yoreh Biotechnologies Ltd. Whole blood/mitogen assay for the early detection of a subject with cancer and kit
US6322989B1 (en) 1991-11-25 2001-11-27 Yoreh Biotechnologies, Ltd. Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit
PT1024191E (pt) 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
CA2118015A1 (en) 1992-04-14 1993-10-28 Jeffrey R. Marks Method of detecting tumors containing complexes of p53 and hsp70
US5801005A (en) 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US5763164A (en) 1993-04-16 1998-06-09 Northwestern University Immunogenic cancer proteins and peptides and methods of use
US5747268A (en) 1993-04-22 1998-05-05 Dade International Inc. Tumor marker control
CN1097252A (zh) * 1993-07-03 1995-01-11 首钢总公司 多元同步标记分析法
US5744144A (en) 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
US5721105A (en) 1994-02-20 1998-02-24 B.R.A.H.M.S. Diagnostica Gmbh Method for the immunological determination of proteins and kit for carrying out the method
JPH07294530A (ja) * 1994-04-20 1995-11-10 Nippon Igaku Rinshiyou Kensa Kenkyusho:Kk 病原体に対する体液中の抗体検出法
CA2148971A1 (en) 1994-05-26 1995-11-27 Izak Bahar Calibrator matrix
EP0764030B1 (en) 1994-06-24 2000-09-20 Vladimir P. Torchilin Composition containing autoantibodies for tumor therapy and prophylaxis
IL110464A0 (en) 1994-07-26 1994-10-21 Univ Ramot Novel proteins for the diagnosis, imaging, and therapy of human cancer
US5561049A (en) 1994-09-21 1996-10-01 Behringwerke Ag Method for detecting antibodies
US5876728A (en) 1995-02-15 1999-03-02 Howard David Kass Natural composition extracted from plants used in the treatment of cancer
AUPN568095A0 (en) 1995-09-27 1995-10-26 Austin Research Institute, The Anti-Galalpha(1,3)Gal antibody binding peptides
GB9521544D0 (en) 1995-10-20 1995-12-20 Univ Dundee Activation of P53 protein and therapeutic applications thereof
JPH09189702A (ja) 1996-01-09 1997-07-22 Hitachi Chem Co Ltd 抗ムチン抗体の測定法、癌の測定法及び癌診断薬
ATE283069T1 (de) 1996-08-16 2004-12-15 Univ Johns Hopkins Med Melanomzellinien, welche immundominante melanomantigene teilen und verfahren zu deren anwendung
CN1044092C (zh) * 1997-02-26 1999-07-14 上海医科大学 抗原-抗体-重组dna复合型疫苗
WO1998055872A1 (en) 1997-06-03 1998-12-10 Amdl, Inc. Immunoassay for the detection of cancer
DE19805815C1 (de) 1998-02-13 1999-11-11 Ansgar W Lohse Diagnostikum zum Erkennen der autoimmunen Hepatitis
JP4083855B2 (ja) 1998-02-16 2008-04-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 肺癌予後検査方法
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
AUPP349098A0 (en) 1998-05-13 1998-06-04 South Eastern Sydney Area Health Service A method of monitoring pancreatic tissue viability
WO2000026668A2 (en) 1998-11-05 2000-05-11 The Regents Of The University Of Michigan S100 proteins and autoantibodies as serum markers for cancer
US6387639B1 (en) 1998-11-10 2002-05-14 Sloan-Kettering Institute For Cancer Research Ma family polypeptides and anti-Ma antibodies
GB9827228D0 (en) 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US7807810B2 (en) 1999-04-08 2010-10-05 The Ohio State University Research Foundation Nucleic acids encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby
US6645465B2 (en) 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer
US20020064801A1 (en) * 1999-12-01 2002-05-30 Ryan Jeffrey R. Novel and practical serological assay for the clinical diagnosis of leishmaniasis
US6667160B2 (en) 2000-03-15 2003-12-23 Kenneth D. Fine Method for diagnosing immunologic food sensitivity
US20030232399A1 (en) 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
US20030138860A1 (en) 2000-06-14 2003-07-24 Robertson John Forsyth Russell Cancer detection methods and reagents
EP1354206A2 (en) 2000-12-13 2003-10-22 Bio-Rad Laboratories, Inc. Standard diluent for multiplex assays
US7745141B2 (en) 2001-06-21 2010-06-29 New York University Mycobacterial proteins as early antigens for serodiagnosis and vaccines
GB0128583D0 (en) * 2001-11-28 2002-01-23 Rsr Ltd Detection of autoantibodies indicative of diabetes
US20030049692A1 (en) * 2002-09-16 2003-03-13 Norman Latov Detection of anti-glycolipid antibodies by latex agglutination assay
GB2395270B (en) * 2002-11-14 2006-08-16 Univ Nottingham Tumour marker proteins and uses thereof
CN1547025A (zh) * 2003-12-03 2004-11-17 刘春杰 高灵敏度酶联免疫分析检测试剂盒
JP2005352771A (ja) 2004-06-10 2005-12-22 Hitachi Software Eng Co Ltd 発現プロファイルによるパターン認識システム
US20060141547A1 (en) 2004-11-16 2006-06-29 Das Hasi R Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
WO2007032634A1 (en) 2005-09-12 2007-03-22 Industry Foundation Of Chonnam National University A method for production of mature natural killer cell
TWI304443B (en) 2005-12-30 2008-12-21 Nat Health Research Institutes Alpha-enolase specific antibody and method of use
CA2663154C (en) 2006-09-13 2016-02-23 Oncimmune Ltd Improved immunoassay methods
CN101632020B (zh) 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
GB0725239D0 (en) 2007-12-24 2008-02-06 Oncimmune Ltd Calibrator for autoantibody assay

Also Published As

Publication number Publication date
ES2458105T3 (es) 2014-04-29
US8722339B2 (en) 2014-05-13
DE602006007703D1 (de) 2009-08-20
EP1889059A2 (en) 2008-02-20
DK1889059T3 (da) 2009-11-02
NO20076656L (no) 2008-02-26
ES2384935T3 (es) 2012-07-16
WO2006126008A2 (en) 2006-11-30
CN101203756B (zh) 2016-03-09
DK2275815T3 (da) 2014-05-12
PT2275815E (pt) 2014-07-10
SI2073008T1 (sl) 2012-08-31
RU2007149281A (ru) 2009-07-10
CA2609793A1 (en) 2006-11-30
KR101400986B1 (ko) 2014-05-28
CN102749447B (zh) 2015-05-13
AU2006250923A1 (en) 2006-11-30
NO339224B1 (no) 2016-11-21
EP2275815A2 (en) 2011-01-19
CN101203756A (zh) 2008-06-18
MX2007014815A (es) 2008-04-11
PL1889059T3 (pl) 2009-12-31
EP2275815B1 (en) 2014-04-02
JP2008542703A (ja) 2008-11-27
EP2073008B1 (en) 2012-04-18
US20080305476A1 (en) 2008-12-11
JP4876127B2 (ja) 2012-02-15
ATE436018T1 (de) 2009-07-15
EP2073008A1 (en) 2009-06-24
CA2609793C (en) 2018-05-22
ES2328171T3 (es) 2009-11-10
CN102749447A (zh) 2012-10-24
PT2073008E (pt) 2012-06-18
KR20080034851A (ko) 2008-04-22
AU2006250923B2 (en) 2012-06-07
GB0510943D0 (en) 2005-07-06
ATE554386T1 (de) 2012-05-15
EP2275815A3 (en) 2011-02-02
GB2426581A (en) 2006-11-29
EP1889059B1 (en) 2009-07-08
RU2416095C2 (ru) 2011-04-10
WO2006126008A3 (en) 2007-03-29
DK2073008T3 (da) 2012-06-04

Similar Documents

Publication Publication Date Title
PL2073008T3 (pl) Ulepszone sposoby prowadzenia testów immunologicznych
BRPI0707645B8 (pt) métodos in vitro para detecção de câncer em um indivíduo e para avaliação de prognóstico de um indivíduo tendo, ou suspeito de ter, câncer ovariano
WO2008135564A3 (en) Assays
ATE476657T1 (de) Vorhersage von letalität und detektion von schweren erkrankungen
EP3293522A3 (en) Lipidomic biomarkers for identification of high-risk coronary artery disease patients
MX2007005053A (es) Metodo para evaluar la enfermedad de alzheimer y reactivo de diagnostico.
ATE360809T1 (de) Schnelltest für biologische substanzen mittels ftir
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
EP1930445A4 (en) KIT AND METHOD FOR DETECTING UROTHELIAL CANCER
DE602006014581D1 (de) Turbidimetrischer immunoassay zur beurteilung von humanem cystatin c
WO2008062048A3 (en) Methods for optically detecting multiple analytes in a liquid sample with a compressible microfluidic device
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
NZ592819A (en) Thyroid analyte detection and measurement
WO2008122447A3 (en) Dna methylation assay for the diagnosis or prognosis of medical conditions
PL1977244T3 (pl) Rozróżnianie bakteryjnego i wirusowego zapalenia opon mózgowych
CY1109461T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
EP2444812A3 (en) Improved immunoassay methods
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
WO2004085669A3 (en) Identification and quantification of microbial species in a sample
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
EP1636587A4 (en) DIAGNOSTIC KIT FOR LIVER CIRRHOSIS COMPRISING A SPECIFIC ANTIBODY OF A HUMAN PROTO-ONCOGEN PROTEIN
CY1115323T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
DK1297342T3 (da) Metode til diagnostisk bestemmelse af Alzheimer's sygdom på basis af holo-transcobalamin II
GB0501564D0 (en) Test for prion disease
CY1113688T1 (el) Βελτιωμενες μεθοδοι ανοσοπροσδιορισμου